US EditionPsychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic Review
Summary by psychiatrist.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Psychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic Review
Psychiatric Adverse Effects From Hydroxychloroquine Use: A Systematic Review Hydroxychloroquine (HCQ) is a hydroxide derivative of chloroquine (CQ). It is approved by the US Food and Drug Administration (FDA) for treating malaria, systemic lupus erythematosus (SLE), discoid lupus erythematosus, and rheumatoid arthritis. The off-label uses include Q-fever, porphyria cutanea tarda, primary Sjogren disease, and sarcoidosis.1–4 Since CQ and HCQ exhi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
